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Objectives
To implement antimicrobial reasonable use and evaluate
its impact on E. coli and K. pneumoniae with ESBLs iso-
lated from hospitalized patients.
Methods
The 2nd/3rd generation cephalosprines (GCPs) use from
2006.1 to 2012.12 was converted to DDDs per 1,000 patient-
days in a tertiary teaching infectious disease hospital in Tian-
jin, China. Multi-strategy, including contextually appropriate
antibiotic use guidelines, active audit, as well as performance
feedback/education in-field, were conducted by antimicro-
bial stewardship in the hospital since 2006. E. coli and
K. pneumoniae isolated from all identified and suspected
infections were selected at the same time. For ESBLs status,
agar diffusion test with clavulanic acid plus or minus cefo-
taxime and ceftazidime was used. Linear correlation was car-
ried out to analyze the relationship between 2nd/3rd GCPs
use and major Enterobacteriaceae producing ESBLs.
Results
The 2nd GCPs consumption was 12.488, 12.563, 12.637,
20.221, 48.598, 6.647, and 8.129 DDDs per 1,000 patient-
days during 2006 to 2012 respectively. The 3rd GCPs con-
sumption was 35.248, 32.135, 31.720, 23.661, 31.696, 20.284
and 15.722 DDDs per 1,000 patient-days respectively at the
same time. ESBL-producing strains rates of E. coli and
K. pneumoniae were 27.42% (17/62), 26.79% (15/56),
29.09% (16/55), 23.53% (24/102), 39.29% (66/168), 25.58%
(33/129) and 11.46% (18/157) from 2006 to 2012 respec-
tively. Lower 2nd/3rd GCPs annually use was associated
with a lower rate of E. coli and K. pneumoniae with ESBLs
isolated from contemporary hospitalized patients. (r2 =
0.843; P < 0.005).
Conclusion
Multi-strategy intervention by antimicrobial stewardship
was effective on commonly used 2nd/3rd GCPs in the
hospital of Tianjin, China. The decrease of 2nd/3rd GCPs
represented a significant driver in the reduction in rate
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